BPS News | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

All posts in BPS News

Boulder Peptide Society Establishes the Young Investigator Award

January 31, 2014 (Boulder, CO) - The Boulder Peptide Society is pleased to announce it is establishing the Boulder
Peptide Young Investigator Award as a new award to be given to a young academic investigator with great potential for scientific contributions to the field of peptide chemistry, formulation, delivery, and analytical characterization.

Boulder Peptide Society prides itself on supporting pioneering science in the peptide field and this award is a way to bring young investigators to the meeting to meet colleagues, potential collaborators, and companies with interest in new technologies.

The award recipient will speak at the Boulder Peptide Symposium on September 22, 2014.  The award winner will receive an honorarium in addition to paid travel, hotel, and registration, which will be covered by the Boulder Peptide Society.

Boulder Peptide Society Announces New SAB and 2014 Meeting

Boulder, CO, November 23, 2013 --(PR.com)-- The Boulder Peptide Symposium will host its 8th Annual meeting in late September 2014. In preparation, the symposium board of trustees has assembled an esteemed Scientific Advisory Board to foster the event. The SAB brings together experts from industry and academia with a significant body of experience in discovery and development of peptide therapeutics.

John Carpenter, Ph.D.
Professor of Pharmaceutical Sciences and Co-Director of the Center for Pharmaceutical Biotechnology, University of Colorado, Anschutz Medical Campus, Denver
 
Waleed Danho, Ph.D.
Consultant, formerly Distinguished Research Leader, Hoffmann La Roche
 
Phil Dawson, Ph.D.
Associate Professor & Associate Dean of Graduate Studies, The Scripps Research Institute, La Jolla
 
Nader Fotouhi, Ph.D.
Vice President, Pharma Research and Early Development Site Leader, Hoffmann La Roche, Nutley
 
Tomas Landh, Ph.D.
Director of Strategy and Innovation Sourcing, Novo Nordisk, Denmark
 
Barbara Lueckel, Ph.D.
Global Business Development Director, F. Hoffman-La Roche Ltd., Basel
 
John Mayer, Ph.D.
Senior Research Scientist, University of Indiana
 
Chris Rhodes, Ph.D.
Consultant in Pharmaceutical Technology, formerly Executive Director, Pharmaceutical R&D, Amylin Pharmaceuticals
 
Tomi Sawyer, Ph.D.
Entrepreneurial Drug Hunter, Adjunct Professor, University of Massachusetts and UMass Medical School, formerly Chief Scientific Officer, Aileron Therapeutics
 
Ved Srivastava, Ph.D.
Head, Peptide Chemistry, GlaxoSmithKline
 
Elizabeth Topp, Ph.D.
Dane O. Kildsig Chair and Head of the Department of Industrial and Physical Pharmacy, Purdue University

Each year, the Boulder Peptide Symposium is organized around a theme. The SAB has designed a meeting for 2014 that will be focused broadly on peptides in infectious disease, including anti-virals, anti-microbials, and neglected diseases. Special emphasis will be given to platform technologies designed to create constrained peptide structures with improved properties.

The Boulder Peptide Symposium is a nonprofit organization. More information about the mission and the annual meeting can be found on the website at www.boulderpeptide.org.

The 8th Annual meeting will take place at the St. Julien Hotel and Spa in Boulder Colorado on Sept 22 to 24, 2014.

Read the full press release on www.pr.com

New Speaker Alert: Dr Laurie Parker, of Purdue University

Dr Laurie shall be presenting on the application of peptides as biosensors to monitor intracellular signalling pathways. Check the BPS website soon for an abstract.


s2Member®
loading...